Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:07 p.m.

    📋 HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) - Financial Results

    Filing Date: 2022-08-02

    Accepted: 2022-08-02 07:45:30

    Event Type: Financial Results

    Event Details:

    Harmony Biosciences (HRMY) Reports Q3 2022 Financial Results Harmony Biosciences (HRMY) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 20160
    • Net Income: 0.57
    • EPS: $0.00
    • Cash and equivalents: 236533

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Interest Expense -7.23K -8.10K $869.00 +10.73%
    Noncurrent Assets Property Equipment Net 695.00 695.00 $0.00 +0.00%
    Noncurrent Assets Intangible Assets Net 172.88K 172.88K $0.00 +0.00%
    Revenue 73.82K 192.34K $-118.52K -61.62%
    Interest Expense -7.23K -8.10K $869.00 +10.73%
    Property and Equipment, Net 820.00 695.00 $125.00 +17.99%
    Intangible Assets, Net 143.92K 172.88K $-28.96K -16.75%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Harmony Biosciences
    • CIK: 0001802665
    • Ticker Symbol: HRMY
    • Period End Date: 2022-08-02
    • Document Type: 8-K

Search

News categories